{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:06:56Z","timestamp":1770822416384,"version":"3.50.1"},"reference-count":36,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Urology and Nephrology"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1080\/00365590310006345","type":"journal-article","created":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T20:27:15Z","timestamp":1078432035000},"page":"19-25","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy"],"prefix":"10.1080","volume":"38","author":[{"given":"Daniele","family":"Minardi","sequence":"first","affiliation":[{"name":"Institute of Urology, University of Ancona Medical School, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea B.","family":"Galosi","sequence":"additional","affiliation":[{"name":"Institute of Urology, University of Ancona Medical School, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Giannulis","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Ancona Medical School, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Ancona Medical School, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Polito","sequence":"additional","affiliation":[{"name":"Institute of Urology, University of Ancona Medical School, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Muzzonigro","sequence":"additional","affiliation":[{"name":"Institute of Urology, University of Ancona Medical School, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pros.2990250705","volume":"5","author":"Schulmann CC","year":"1994","journal-title":"Prostate Suppl"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67067-8"},{"key":"CIT0003","unstructured":"Witjes W, Schulman C, Forster G, Debruyne F, Van Cangh P. Fava C for the European Study Group on Neoadjuvant Treatment. Neoadjuvant combined andro-gen deprivation therapy in T2-3NOMO prostatic carcino-ma. Early results of a European study. Eur Urol 1996; 30 (Suppl 2): 210 (A775)."},{"key":"CIT0004","first-page":"221","volume":"9","author":"Polito M","year":"1995","journal-title":"Acta Urol Ital"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.10.906"},{"key":"CIT0006","first-page":"821","volume":"68","author":"Murphy MW","year":"1991","journal-title":"Pathologic changes associated with androgen deprivation therapy for prostatic cancer. Cancer"},{"issue":"1","key":"CIT0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000474242","volume":"30","author":"Polito M","year":"1996","journal-title":"Eur Urol"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0090-4295(00)00866-9","volume":"57","author":"Bono AV","year":"2001","journal-title":"Urology"},{"key":"CIT0009","first-page":"201","volume":"195","author":"Montironi R","year":"1999","journal-title":"Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer: initial results of the Italian PROSIT study. Pathol Res Pract"},{"key":"CIT0010","first-page":"189","volume":"2","author":"Pagano F","year":"1998","journal-title":"Neoadjuvant hormone therapy before surgery for pros-tate cancer. The Italian experience. Mol Urol"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0022-5347(17)37630-9","volume":"147","author":"Petros JA","year":"1992","journal-title":"J Urol"},{"key":"CIT0012","first-page":"269","volume":"52","author":"Bundrick WS","year":"1993","journal-title":"Evaluation of the current incidence of nodal meta-stases from prostate cancer. J Surg Oncol"},{"key":"CIT0013","first-page":"1154","volume":"189","author":"Magi-Galluzzi C","year":"1993","journal-title":"al. Prostatic invasive adenocarcinoma: effect of combination endocrine ther-apy on the expression and location of proliferative cell nuclear antigen (PCNA). Pathol Res Pract"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(86)90520-3"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0022-5347(01)66162-7","volume":"155","author":"Cher ML","year":"1996","journal-title":"J Urol"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(86)90520-3"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/BF01008010"},{"key":"CIT0018","first-page":"311","volume":"20","author":"Bazinet M","year":"1992","journal-title":"Prognostic significance of antigenic heterogeneity, Gleason grade and ploidy of lymph node metastases in patients with prostate cancer. Prostate"},{"key":"CIT0019","first-page":"278","volume":"118","author":"Barzell W","year":"1977","journal-title":"Jr. Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol"},{"key":"CIT0020","first-page":"1225","volume":"66","author":"McNeal JE","year":"1990","journal-title":"Histologic differentiation, cancer volume and pelvic lymph node metastasis in adenocarcinoma of the pros-tate. Cancer"},{"key":"CIT0021","first-page":"617","volume":"133","author":"Smith JA","year":"1985","journal-title":"Implication of volume of nodal metastases in patients with prostatic carcinoma. J Urol"},{"key":"CIT0022","first-page":"2504","volume":"47","author":"Stephenson RA","year":"1987","journal-title":"Cancer Res"},{"key":"CIT0023","unstructured":"Peters-Gee JM, Miles BJ, Cerny JC, Gaba A, Crissman JD. DNA quantification in stage D1 prostatic adenocar-cinoma metastases. J Urol 1991; 145: 156 (251A)."},{"key":"CIT0024","first-page":"158","volume":"15","author":"Babiarz J","year":"1993","journal-title":"Anal Quant Cytol Histol"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Zinke H, Bargstralh EJ, Larsonn-Keller JJ, Farrow GM, Myers RP, Lieber MM, et al. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer 1992; 70 (Suppl): 311\u201323.","DOI":"10.1002\/1097-0142(19920701)70:1+<311::AID-CNCR2820701320>3.0.CO;2-T"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<129::AID-PROS9>3.0.CO;2-B","volume":"28","author":"Hobisch A","year":"1996","journal-title":"Prostate"},{"key":"CIT0027","first-page":"223","volume":"157","author":"Gburek BM","year":"1997","journal-title":"Chromosomal anomalies in stage D-1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescent in situ hybridization. J Urol"},{"key":"CIT0028","first-page":"129","volume":"13","author":"Montironi R","year":"1993","journal-title":"Is the proliferative state in the marginal zone of the tumor higher than in the central part? Anticancer Res"},{"key":"CIT0029","first-page":"660","volume":"43","author":"Spires SE","year":"1994","journal-title":"Proliferating cell nuclear antigen in prostatic adenocarcinoma: correlation with established prognostic indicators. Urology"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.1711680103","volume":"168","author":"Visakorpi T","year":"1992","journal-title":"J Pathol"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(17)36104-9","volume":"149","author":"Carroll PR","year":"1993","journal-title":"J Urol"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1464-410X.1997.33215.x","volume":"79","author":"Schemeller N","year":"1997","journal-title":"Br J Urol"},{"key":"CIT0033","first-page":"332","volume":"142","author":"Gervasi LA","year":"1989","journal-title":"Prognostic significance of lymph nodal metastases in prostate cancer. J Urol"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45519-4"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0094-0143(21)01380-X","volume":"17","author":"Ausenfeld MS","year":"1990","journal-title":"Urol Clin North Am"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.7.508"}],"container-title":["Scandinavian Journal of Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365590310006345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T15:16:13Z","timestamp":1624461373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365590310006345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["10.1080\/00365590310006345"],"URL":"https:\/\/doi.org\/10.1080\/00365590310006345","relation":{},"ISSN":["0036-5599","1651-2065"],"issn-type":[{"value":"0036-5599","type":"print"},{"value":"1651-2065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}